PRAXOLE XR pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

pramipexole dihydrochloride monohydrate, Quantity: 3 mg

Inapatikana kutoka:

Arrotex Pharmaceuticals Pty Ltd

INN (Jina la Kimataifa):

pramipexole dihydrochloride monohydrate

Dawa fomu:

Tablet, modified release

Tungo:

Excipient Ingredients: magnesium stearate; silicon dioxide; hypromellose; calcium hydrogen phosphate

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

30, 10

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

For the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.

Bidhaa muhtasari:

Visual Identification: White or nearly white, cylindrical and biconvex tablets marked with 210 on one side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2015-06-17